Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Swiss-Based Pharma Packager to Open First U.S. Manufacturing Plant in Spring

By Hoffmann Neopac | December 17, 2018

(Images credit: Hoffmann Neopac)

Switzerland-based Hoffmann Neopac, a global provider of packaging for a broad array of industries and applications, has earmarked two of its small-diameter Polyfoil tubes for production at its first U.S. manufacturing facility, which is scheduled to open in spring 2019.

The 37,000-square-foot Wilson, NC plant will feature a high-speed tube line as part of an operation capable of producing some 80 million tubes annually. The new plant will have floor space for several additional packaging lines to meet anticipated North American growth in the small tubes niche, especially in the pharma, cosmetics, and animal health sectors, but also for emerging applications such as cannabis-based creams and liquids.

Twist’n’Use is a small-volume single-dose tube that, once the cap is twisted, is irrevocably opened.

Like all tubes to be manufactured at the North Carolina facility, the two new small-diameter tubes utilize Neopac’s Polyfoil technology, a proprietary blend of materials providing advanced barrier properties for products requiring ample protection against moisture, oxygen, and other potentially harmful external factors.

Products housed in Polyfoil can enjoy a longer shelf life compared to those stored in conventional polyethylene (PE) or polypropylene (PP) packaging, according to the company.

Tube products slated for production at the new U.S. facility include tamper-evident nozzle tube suited for topical disinfectants, eye ointments, eye creams and gels, and Twist’n’Use tube for small-volume single-dose usage  across the pharmaceutical and cosmetic sectors, including applications for animal health, first aid products, and dietary supplements.

Privately owned Hoffmann Neopac is headquartered in Thun, Switzerland.

(Source: Hoffmann Neopac)

Related Articles Read More >

Artis BioSolutions announces new center of excellence in Spain
Bristol Myers Squibb’s RazyeBio to build $173 million Indiana facility 
Bristol Myers Squibb to build new plant in Houston 
Hygiene women worker work in science laboratory. people in pharmaceutical medicine production machine inspector.
How computer vision can improve defect detection and traceability in pharma inspection
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE